biontech

Business

Merkel pushes to speed up vaccine roll-out, as German lockdown tightens

Chancellor Angela Merkel called an emergency meeting to speed up Germany’s Covid-19 vaccine program in an effort to quell tensions…

Read More »
Business

EU seeks an additional 300 million Pfizer-BioNTech vaccine doses

The European Union is negotiating with Pfizer Inc. and BioNTech SE on a deal that could double their supply of…

Read More »
Business

The U.K. approves AstraZeneca Covid-19 vaccine

Our mission to make business better is fueled by readers like you. To enjoy unlimited access to our journalism, subscribe today.…

Read More »
Business

Pfizer to supply U.S. with 100 million more vaccine doses

Pfizer and partner BioNTech agreed to supply an additional 100 million doses of their COVID-19 vaccine to the U.S., as…

Read More »
Business

BioNTech CEO says the vaccine will likely work on new U.K. virus variant

Pfizer Inc. partner BioNTech SE is pursuing all its options to make more Covid-19 vaccine doses than the 1.3 billion…

Read More »
Business

‘There simply isn’t the trust’: How public-health authorities are trying to overcome vaccine skepticism

Now that the much-anticipated coronavirus vaccines are starting to be distributed across the United States, Cheryl Stokes is looking forward…

Read More »
Business

Photos: U.S. health workers begin receiving COVID-19 vaccine

Our mission to make business better is fueled by readers like you. To enjoy unlimited access to our journalism, subscribe today.…

Read More »
Business

UAE says China’s state-backed COVID-19 vaccine is 86% effective

Our mission to make business better is fueled by readers like you. To enjoy unlimited access to our journalism, subscribe today.…

Read More »
Business

Commentary: If we don’t vaccinate the world quickly, all our COVID efforts will be a waste

The promising results announced by Pfizer and BioNTech in their coronavirus vaccine candidate mark a significant step toward overcoming COVID-19.…

Read More »
Business

Goldman Sachs raises its S&P 500 target on vaccine hopes

Our mission to make business better is fueled by readers like you. To enjoy unlimited access to our journalism, subscribe today.…

Read More »
Back to top button